Glaucoma Diagnosis: First 90 Days

A glaucoma diagnosis can feel overwhelming, but the first 90 days are crucial for understanding your condition, starting treatment, and establishing a plan to protect your vision long term. Early follow-up, regular eye pressure monitoring, and clear communication with your glaucoma specialist can make a significant difference in preserving sight.

Your First 90 Days With Glaucoma: A Step-by-Step Action Plan

Many patients ask me: I have been diagnosed with glaucoma. What do I do now. Here is what I tell them: A glaucoma diagnosis does not mean you are going blind. It means you now have information most people get too late. The next 90 days are the most important window — not because the disease moves fast, but because the habits you build now protect your vision for the next 30 years.

This guide, written by Dr Shibal Bhartiya, tells you exactly what to do, in order.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Day 1–7 of Glaucoma Diagnosis: Get the Basics Right

Learn to put in your eye drops correctly

This is the single most important skill you will learn. Studies show that over 60% of patients use eye drops incorrectly — and incorrect technique means the drop misses the eye, or drains immediately into the tear duct and does nothing.

Do this:

Wash your hands. Tilt your head back. Pull your lower eyelid gently down to form a pocket. Hold the bottle above the eye without touching it. Squeeze one drop into the pocket — not onto the eyeball directly. Close your eye gently. Press the inner corner of your eye (near the nose) firmly with one finger for 60 seconds. This blocks the tear duct and keeps the drug in the eye where it belongs. Do not blink vigorously. Do not wipe.

If you use more than one drop type, wait five minutes between them. The first drop dilutes and flushes out the second if you use them together.

Ask your doctor or optometrist to watch you do it once. Ask for a correction if your technique needs adjustment.

Here’s a video demostration:

Set your alarms — and take them seriously

Glaucoma drops work only when taken on time, every day, for life. A single missed day matters less than a pattern of casual delays.

Most drops are once daily, ideally at night. Set a recurring alarm on your phone with a label — “Left eye drop, right eye drop, press corner.” Place the bottle next to your toothbrush. The habit links to the existing habit.

If you use drops twice daily, set both alarms. Never rely on memory alone.

File your papers before they disappear

You walked out of the clinic with reports. Photograph or scan every one of them today — the visual field test, the OCT nerve scan, the IOP readings, the prescription. Put them in a dedicated folder on your phone or email them to yourself with the subject line “Glaucoma Records — [your name].”

You will need these at your next visit, at any second opinion, and if you travel and need emergency eye care. Doctors cannot make good decisions without your baseline.


Week 2–4 of Glaucoma Diagnosis: Build the Follow-Up Structure

Your 30-day appointment is not optional

Glaucoma drops take four to six weeks to show their full pressure-lowering effect. Your doctor needs to see you at 30 days to measure whether the drop is working — and to catch side effects early. Do not skip this.

At this visit, your doctor will check:

  • Your intraocular pressure (IOP) against your baseline
  • Whether the drop is causing redness, allergy, or discomfort
  • Whether you need a dose adjustment or a switch to a different medication

Set a calendar reminder for this appointment the day you are diagnosed. If the appointment was not scheduled, call the clinic and schedule it yourself before the week is over.

Know what side effects to watch for

Most glaucoma drops are well-tolerated. But some cause changes you should know about.

Prostaglandin analogues (bimatoprost, travoprost, latanoprost) can darken the iris over time in some patients, and may cause eyelash growth or mild redness. These are cosmetic and not dangerous — but tell your doctor.

Beta-blockers (timolol) can slow your heart rate and cause breathlessness in patients with asthma or heart disease. If you feel unusually short of breath or very tired after starting drops, contact your doctor the same day.

Alpha agonists (brimonidine) sometimes cause an allergic reaction with marked redness and discharge, usually within weeks of starting. Stop the drop and call your doctor if this happens.

None of these mean you must stop treatment. They mean the treatment may need adjustment.


Month 1–2 of Glaucoma Diagnosis: Tell Your Family

Your siblings and children need an eye check — now

Glaucoma has a strong genetic component. First-degree relatives of a glaucoma patient have a four to nine times higher risk of developing the disease. Most of them will have no symptoms at all until damage is advanced.

Tell your siblings and adult children this week. Ask them to see an ophthalmologist for a baseline pressure check, optic nerve assessment, and field test. This is not alarmist. It is the most useful thing your diagnosis can do for your family.


Month 1–3: Address the Controllable Risk Factors

Stop smoking — this one is not negotiable

Smoking constricts blood vessels and reduces blood flow to the optic nerve. It worsens the vascular risk that many glaucoma patients already carry. The damage from smoking adds to the damage from pressure — and your nerve cannot absorb both.

If you smoke, speak to your doctor about cessation support. This is as important as the drops.

Get your metabolic parameters checked

High blood pressure, diabetes, thyroid disease, and sleep apnoea all affect glaucoma progression through vascular and metabolic pathways. If these are uncontrolled, your optic nerve faces risk from two directions simultaneously.

Ask your physician to check your blood pressure, fasting glucose, HbA1c, and thyroid function if these have not been done recently. If you snore heavily or feel exhausted in the mornings, mention it — untreated sleep apnoea is a recognised glaucoma risk factor that is almost always missed.

Exercise — the right kind

Moderate aerobic exercise (brisk walking 30 minutes, five days a week) lowers intraocular pressure by a clinically meaningful amount in most patients. Avoid high-resistance head-down exercises like heavy weightlifting or inverted yoga poses — these transiently spike IOP.


Month 2–3: Ask About Laser Treatment

SLT — Selective Laser Trabeculoplasty

If your glaucoma is open-angle type, your doctor may recommend SLT as a first-line treatment or as a supplement to drops. SLT uses a laser to improve fluid drainage from the eye. It is done in the clinic in five to ten minutes, is painless, and works in approximately 75 to 80% of patients.

The effect lasts three to five years and can be repeated. SLT does not burn tissue — it sends a gentle energy pulse that stimulates the drainage cells to work better.

Ask your doctor at the 30-day or 90-day visit: “Am I a candidate for SLT?”

LPI — Laser Peripheral Iridotomy

If your glaucoma is narrow-angle or angle-closure type, LPI is a preventive procedure that creates a small opening in the iris to prevent a sudden pressure spike (acute angle-closure attack). LPI is typically recommended before an attack happens — it takes three to four minutes per eye and prevents one of the most painful ophthalmic emergencies.

If your doctor mentioned narrow angles at any point, ask specifically whether you need LPI. Do not wait.


Throughout: Keep Your Perspective

Do not search the internet at 2am

Glaucoma outcomes in treated patients are overwhelmingly good. The disease moves slowly in the vast majority of cases. Patients who take their drops, attend follow-ups, and manage their risk factors maintain useful vision for life in most cases.

The stories of severe vision loss you will find online mostly involve patients who were never diagnosed, or who stopped treatment. You are neither.

Reach out if you need support

A new diagnosis changes how you think about your body. Some patients find this unsettling, and that is entirely normal. Several Indian and international glaucoma patient forums, and online communities run by ophthalmologists offer peer support from people at every stage of the same journey.

You do not have to figure this out alone.


Your 90-Day Checklist

  • Eye drop technique confirmed by a doctor or technician
  • Alarm set — every day, same time
  • All reports photographed and filed digitally
  • 30-day follow-up appointment booked
  • Side effects list saved on your phone
  • Siblings and adult children informed and booked for screening
  • Smoking cessation initiated if applicable
  • Blood pressure, glucose, HbA1c, thyroid checked
  • SLT or LPI discussion had with your doctor
  • One support resource bookmarked

Frequently Asked Questions

Do I have to take eye drops for life?

In most cases, yes. Glaucoma is a chronic condition and eye drops control pressure — they do not cure the disease. Stopping drops allows pressure to rise again and damage to resume. Some patients reduce or stop drops after successful laser treatment (SLT), but this is a decision made with your doctor based on your pressure readings, not independently.

What if I forget a drop one day?

Take it as soon as you remember, unless it is almost time for the next dose. Do not double up. One missed dose will not cause a crisis. A habit of casual misses will. Reset the alarm and continue.

Can I drive after putting in my eye drops?

Most glaucoma drops do not affect vision significantly. Some patients notice mild blurring for a few minutes immediately after instillation — wait for this to clear before driving. If your doctor has dilated your pupils at a clinic visit, do not drive until dilation wears off, typically three to four hours.

My pressure was normal at diagnosis. Do I still have glaucoma?

Yes — this is called normal-tension glaucoma (NTG). Roughly 30 to 40% of glaucoma patients in India have pressures within the statistical normal range. The diagnosis is made on optic nerve appearance and visual field changes, not pressure alone. NTG is treated the same way — the target is to lower pressure further from your individual baseline.

Is glaucoma hereditary? Do I need to tell my family?

Yes, and yes. First-degree relatives — parents, siblings, children — have a four to nine times higher risk. Most will have no symptoms. Tell them this week and ask them to see an ophthalmologist for a baseline check that includes pressure, nerve assessment, and a visual field test.

Will I go blind?

Treated glaucoma in a compliant patient who attends follow-up carries a very low risk of blindness. The risk is real only when the disease is undiagnosed, undertreated, or ignored. You have been diagnosed. That is the most important step already taken.

What is SLT and should I ask about it?

Selective Laser Trabeculoplasty (SLT) is a five-minute clinic procedure that improves fluid drainage from the eye. It works in approximately 75 to 80% of open-angle glaucoma patients and can reduce or eliminate the need for drops for three to five years. Ask your doctor at the 30-day visit whether you are a candidate.

Can I exercise with glaucoma?

Yes — moderate aerobic exercise is actively beneficial and lowers IOP. Brisk walking, cycling, and swimming are all good. Avoid heavy resistance training with breath-holding (Valsalva manoeuvre) and inverted positions, both of which spike pressure transiently. If exercise is a regular part of your routine, tell your doctor so they can factor it into your pressure readings.

My drops are making my eyes red. Should I stop?

Do not stop without speaking to your doctor first. Redness is common with several drop classes and is often manageable — a preservative-free formulation or a switch in medication resolves it in most cases. Stopping drops independently allows pressure to rise. Call the clinic and describe the symptom.

How often will I need follow-up forever?

Once stable on treatment, most patients are reviewed every three to six months. This includes a pressure check and, once yearly or more often if needed, a repeat visual field test and OCT nerve scan to confirm the disease is not progressing. Glaucoma never becomes self-managing — the follow-up rhythm continues for life, but it is not onerous once the initial titration phase is complete.


This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care and monitoring. Please also read our guide to Understanding Your Visual Field Test. You may want to read a patient’s experience with glaucoma eye drops, and of one with SLT.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


More Glaucoma Eye Drops is Not Better Glaucoma Care

More glaucoma eye drops do not guarantee better control. Treatment must be individualised based on riskprogression, and tolerance. Overmedication can increase side effects, reduce adherence, and still fail to protect long-term vision, explains Dr Shibal Bhartiya. Adding more glaucoma medications does not always mean better care and may reflect disease progression requiring proper reassessment.

When glaucoma worsens, many patients assume the next step is simple: add more eye drops.
But glaucoma care is not about the number of medicines. It is about protecting the optic nerve safely over a lifetime.

Sometimes adding drops helps. Sometimes it harms. Good care depends on judgement, sequencing, and long-term strategy.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Glaucoma Is a Long-Arc Disease

Glaucoma damage is slow, silent, and irreversible.

Treatment must balance:

The goal is not perfect numbers. The goal is lifelong, stable vision.


What Is Target Eye Pressure?

Every patient has a target intraocular pressure (IOP), a level considered safe for their optic nerve.

This depends on:

Two patients with the same pressure may need very different treatment. Glaucoma care is about staying below your safe pressure consistently, not just lowering it once.

Dr Bhartiya, along with her colleagues in Australia and Switzerland, has published peer-reviewed research on current perspectives on Target IOP in glaucoma practice, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes. Her 2014 paper, Target Intraocular Pressure: Approaches and Options, examines how glaucoma specialists should set, communicate, and revise pressure targets, balancing clinical evidence, patient preferences, and long-term vision outcomes. It is cited by glaucoma surgeons internationally and is freely available on PubMed.


When More Eye Drops Are Not Better

Adding multiple medications can lead to:

  • Redness, burning, and irritation
  • Allergy and eyelid swelling
  • Severe dryness
  • Complex dosing schedules
  • Poor adherence

In some cases, pressure appears controlled, but damage continues.

More medication does not always mean better protection.


What Is Maximal Medical Therapy?

Maximal medical therapy refers to using the maximum safe combination of eye drops before considering laser or surgery.

But “maximum” is not always “optimal.”

It can result in:

  • Ocular surface damage
  • Poor compliance
  • Fluctuating eye pressure
  • Reduced quality of life

In many cases, laser or surgery may be safer than adding more drops. Glaucoma care is not reactive, it is risk-governed.


Fixed-Dose Combination Drops: A Smarter Approach

Fixed-dose combinations combine two medications in one bottle.

They help by:

  • Reducing the number of drops
  • Simplifying treatment
  • Improving adherence
  • Lowering preservative exposure

Often, simpler regimens protect vision better than complex ones.


What Is Preservative Load?

Many glaucoma drops contain preservatives. Using multiple medications increases cumulative preservative exposure, which can damage the eye surface.

This may cause:

Reducing drops, or using preservative-free options, can significantly improve comfort and safety.


Why More Glaucoma Drops is Not Better Glaucoma Care

SituationWhat Patients Often ThinkWhat Is Actually HappeningWhat Better Care Looks Like
Pressure still high“Add another drop”Target pressure may be wrong or disease is progressing despite treatmentReassess diagnosis, stage, and target pressure
Multiple drops prescribed“More medicines = stronger treatment”Overmedication increases side effects without improving outcomesRationalise drops, simplify regimen
Eyes becoming red / irritated“Drops are working but causing minor issues”Ocular surface damage from preservatives affecting adherenceSwitch to preservative-free or reduce drop burden
Vision feels worse despite “good reports”“Tests are normal, so everything is fine”Functional loss or fluctuation not captured in routine examsCorrelate symptoms with OCT + visual fields
Frequent drop changes“Doctor is trying different combinations”Lack of structured long-term planEstablish stable, personalised treatment pathway
Difficulty remembering drops“I just need to be more careful”Complex regimens reduce compliance and effectivenessSimplify treatment or consider laser (SLT)
Long-term progression“Glaucoma just gets worse over time”Inadequate monitoring or delayed escalationTimely escalation: laser or surgery when needed

Glaucoma Care Is Not Just About Pressure

Effective glaucoma management looks beyond numbers:

  • Optic nerve structure
  • OCT trends over time
  • Visual field progression
  •  Target IOP
  • Medication tolerance
  •  Lifestyle and adherence

More treatment is not always better treatment. The right treatment, at the right time, matters more.

Clinical Reality (What’s Not Always Obvious)

  1. More drops does not mean better control
    Adding medications can feel like escalation, but without reassessing the disease, it may not improve long-term outcomes.
  2. A “good” pressure reading can be misleading
    One normal reading does not guarantee stability—glaucoma damage can continue silently between visits.
  3. Treatment can become habit instead of strategy
    Over time, care may drift into simply adding or switching drops rather than redefining targets and plans.
  4. Side effects quietly affect outcomes
    Multiple preserved drops can irritate the ocular surface, making patients less consistent with treatment.
  5. Stable reports don’t always mean stable disease
    Individual tests may look fine, but progression often appears only when data is tracked over time.
  6. Complex regimens reduce adherence
    The more complicated the schedule, the harder it becomes to follow consistently—reducing real-world effectiveness.
  7. Escalation is often delayed
    Laser or surgery may be postponed because “something is being done,” even if it’s no longer enough.
  8. Follow-up gaps change the disease trajectory
    Longer intervals without structured review can allow subtle progression to go unnoticed.
  9. Targets are not always redefined
    As glaucoma advances, the required pressure often needs to be lower—but this isn’t always updated.
  10. Activity is mistaken for effectiveness
    More visits, more drops, more changes—these can create the illusion of control without actually protecting vision.

When Laser or Surgery May Be Safer

Laser or surgery may be recommended if:

  • Target pressure is not achieved
  • Drops cause significant side effects
  • Adherence is difficult
  • Disease continues to progress
  • Risk of vision loss is high

These decisions are about long-term safety, not treatment failure.


Signs Your Glaucoma Treatment Needs Review

Consider a second opinion if you notice:

  • Increasing number of medications
  • Persistent redness or irritation
  • Confusing or difficult schedules
  • “Normal” pressure but worsening tests
  • High cost or poor affordability
  • Reduced quality of life

Treatment should feel sustainable and tolerable.


Why an Independent Glaucoma Review Helps

Glaucoma decisions are complex and long-term.

structured second opinion can help:

  • Reconfirm diagnosis
  • Reassess target IOP
  • Simplify medications
  • Identify better options
  • Avoid overtreatment

Especially important if you are on 3 or more eye drops.


The Real Goal of Glaucoma Care

Not perfect pressure numbers. Not maximum medications.

The goal is:

  • Right treatment
  • Right timing
  • Minimal burden
  • Long-term stability

More eye drops do not always mean better care.


FAQs

1. Do more glaucoma eye drops mean better treatment?

No. More drops do not necessarily improve outcomes. Treatment must be tailored to your risk profile and disease progression, not just escalated.


2. How many glaucoma drops are too many?

There is no fixed number, but if you are on 3 or more medications, your treatment strategy should be reviewed for effectiveness, tolerance, and alternatives.


3. Why do glaucoma drops stop working?

Glaucoma may progress despite treatment, or medications may become less effective over time. Poor adherence and incorrect sequencing also play a role.


4. What are the side effects of multiple glaucoma drops?

Common side effects include redness, burning, dryness, allergy, blurred vision, and poor tolerance, especially with long-term use.


5. What is target eye pressure in glaucoma?

Target IOP is the pressure level considered safe for your optic nerve. It varies based on damage, age, and progression risk.


6. Are laser or surgery better than eye drops?

In some cases, yes. If drops are not effective or tolerated, laser or surgery may offer safer long-term control.


7. What are fixed combination glaucoma drops?

These combine two medications in one bottle, helping reduce drop burden, improve compliance, and lower preservative exposure.


8. When should I get a second opinion for glaucoma?

If you are on multiple drops, still progressing, or experiencing side effects, a second opinion can help optimise your treatment plan.

 Book a glaucoma care review

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Ethical Glaucoma Care

Glaucoma is a chronic disease that often requires lifelong monitoring and treatment decisions that affect patients for decades. Ethical glaucoma…